|
|
||||||||
The Journal of Immunology, Vol 146, Issue 5 1661-1666, Copyright © 1991 by American Association of Immunologists
ARTICLES |
R Fuleihan, W Mourad, RS Geha and T Chatila
Division of Immunology, Children's Hospital Boston, MA 02115.
The staphylococcal exotoxin toxic shock syndrome toxin-1 (TSST-1) has been demonstrated to bind to monomorphic determinants on MHC-class II molecules. In this study, we have used TSST-1 to probe the role of MHC- class II molecules in the activation and differentiation of resting human B cells. Highly purified B cells were stimulated with TSST-1, alone or in combination with PMA or with anti-human IgM antibodies (anti-mu) and the resulting B cell proliferation and Ig production were monitored. On its own, TSST-1 failed to induce B cell proliferation or Ig production. However, TSST-1 synergized with PMA and with anti-mu in inducing B cell proliferation in the absence of any added T cells or T cell factors. TSST-1 did not induce or potentiate early activation events associated with anti-mu treatment such as phosphoinositide hydrolysis and Ca2+ mobilization. Also, TSST-1 did not potentiate the capacity of anti-mu to induce the transcription of early activation genes such as c-myc. Finally, in contrast to its capacity to promote mitogen-trigered B cell proliferation, TSST-1 failed to induce the differentiation of B lymphocytes into Ig-secreting cells in the absence of added T cells. These results indicate that TSST-1 delivers a comitogenic signal to B cells via MHC-class II molecules that is distinct from signals delivered via surface mu and further strengthens the role of MHC-class II molecules as signal transducing structures.
This article has been cited by other articles:
![]() |
W. Stohl, D. Xu, S. Zang, K. S. Kim, L. Li, J. A. Hanson, S. A. Stohlman, C. S. David, and C. O. Jacob In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4+ cells and human MHC class II Int. Immunol., October 1, 2001; 13(10): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stohl, D. H. Lynch, G. C. Starling, and P. A. Kiener Superantigen-Driven, CD8+ T Cell-Mediated Down-Regulation: CD95 (Fas)-Dependent Down-Regulation of Human Ig Responses Despite CD95-Independent Killing of Activated B Cells J. Immunol., October 1, 1998; 161(7): 3292 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stohl, J. E. Elliott, D. H. Lynch, and P. A. Kiener CD95 (Fas)-Based, Superantigen-Dependent, CD4+ T Cell-Mediated Down-Regulation of Human In Vitro Immunoglobulin Responses J. Immunol., June 1, 1998; 160(11): 5231 - 5238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Truman, C. Choqueux, J. Tschopp, J. Vedrenne, F. Le Deist, D. Charron, and N. Mooney HLA Class II-Mediated Death Is Induced Via Fas/Fas Ligand Interactions in Human Splenic B Lymphocytes Blood, March 15, 1997; 89(6): 1996 - 2007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |